4th Quarter - Termination
COLAS & ASSOCIATES, LLC for TEVA PHARMACEUTICALS USA, INC.
Income
$10,000
Expenses
—
Terminated
Nov 20, 2024
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
- Issues related to drug patents and labeling requirements.
Foreign entity interest: Teva Pharmaceutical Industries, Ltd. is the parent company of Teva Pharmaceuticals USA, Inc., and the parent company benefits in the success of its subsidiary.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN COLAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.